RSAR: BAA Developing Standardized Case Definitions for Adverse Events
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $250,000 to $700,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Points of contact
-
- Christopher Scott christopher.scott@fda.hhs.gov
- tbd@fda.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Department of Health and Human Services Food and Drug Administration is seeking research and development services to develop standardized case definitions for adverse events potentially associated with unapproved products. This Broad Agency Announcement (BAA) falls under the Research and Development in Physical, Engineering, and Life Sciences NAICS category, with an estimated solicitation release date of June 1, 2026, and a projected award date of August 1, 2026.
The primary point of contact for this opportunity is Christopher Scott, who can be reached at christopher.scott@fda.hhs.gov within the Food and Drug Administration. While specific award values and detailed performance requirements are not currently available, the forecast suggests this will be a complex research project focused on creating standardized methodologies for documenting and analyzing adverse event case definitions. Potential contractors should be prepared to demonstrate expertise in scientific research, medical documentation, and adverse event tracking within a regulatory framework.
Forecast text
RSAR: BAA Developing Standardized Case Definitions for Adverse Events Potentially Associated with Unapproved Products
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast